Position in SYRE
as of Jun 30, 2026
· filed Aug 5, 2026
Position Value
$8,222,626
+$3,205,864 QoQ
Shares Held
92,618
-6.9% QoQ
Ownership
0.105%
of shares outstanding
% of Portfolio
0.42%
of 13F equity value
Holder Rank
#80
of 265 holders
Holding Since
Dec 2024
7 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in SYRE Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026F/m Investments LLC holds $96,471,000 across 24 Biotechnology names. SYRE ranks #4 (8.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TVTX |
Travere Therapeutics, Inc.
|
187,574 | $10,656,078 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
16,783 | $10,464,871 | |
| 3 | COGT |
Cogent Biosciences, Inc.
|
228,688 | $8,850,225 | |
| 4 | SYRE |
Spyre Therapeutics, Inc.
This page
|
92,618 | $8,222,626 | |
| 5 | CORT |
Corcept Therapeutics Inc
|
88,042 | $7,655,251 | |
| 6 | MIRM |
Mirum Pharmaceuticals, Inc.
|
51,483 | $6,027,114 | |
| 7 | CYTK |
Cytokinetics Inc
|
60,891 | $5,187,304 | |
| 8 | MANE |
Veradermics, Inc
|
35,967 | $4,421,782 |
All Filings in SYRE
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $8,222,626 | 92,618 | Shares | Sole | 2026-08-05 | |
| 2026-03-31 | $5,016,762 | 99,460 | Shares | Sole | 2026-05-11 | |
| 2025-12-31 | $3,397,801 | 103,718 | Shares | Sole | 2026-02-03 | |
| 2025-09-30 | $920,006 | 54,893 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $786,613 | 52,546 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $836,502 | 51,844 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $1,136,203 | 48,806 | Shares | Sole | 2025-02-13 | |
| No filing history on record for this holder in this stock. | ||||||